
    
      This study is a double-blind randomized controlled trial designed to establish the
      non-inferiority of Sci-B-Vac® compared to Engerix-B® in adults ≥ 18 years old and the
      superiority of Sci-B-Vac® compared to Engerix-B® in adults ≥ 45 years old. Study subjects are
      randomized 1:1 to receive either a total of 3 injections of Sci-B-Vac® or 3 injections of
      Engerix-B® intra-muscularly (IM) on Days 0, 28, and 168.
    
  